SEARCH

SEARCH BY CITATION

Cited in:

CrossRef

This article has been cited by:

  1. 1
    S. H. Simpson, D. A. Lier, S. R. Majumdar, R. T. Tsuyuki, R. Z. Lewanczuk, R. Spooner, J. A. Johnson, Cost-effectiveness analysis of adding pharmacists to primary care teams to reduce cardiovascular risk in patients with Type 2 diabetes: results from a randomized controlled trial, Diabetic Medicine, 2015, 32, 7
  2. 2
    Dima Omran, Sumit R. Majumdar, Jeffrey A. Johnson, Ross T. Tsuyuki, Richard Z. Lewanczuk, Lisa M. Guirguis, Mark Makowsky, Scot H. Simpson, Pharmacists on primary care teams: Effect on antihypertensive medication management in patients with type 2 diabetes, Journal of the American Pharmacists Association, 2015, 55, 3, 265

    CrossRef

  3. 3
    J. A. Black, S. J. Sharp, N. J. Wareham, A. Sandbæk, G. E. H. M. Rutten, T. Lauritzen, K. Khunti, M. J. Davies, K. Borch-Johnsen, S. J. Griffin, R. K. Simmons, Does early intensive multifactorial therapy reduce modelled cardiovascular risk in individuals with screen-detected diabetes? Results from the ADDITION-Europe cluster randomized trial, Diabetic Medicine, 2014, 31, 6
  4. 4
    M. Shawn McFarland, Juliet P. Wallace, Jessica Parra, Jennifer Baker, Evaluation of Patient Satisfaction with Diabetes Management Provided by Clinical Pharmacists in the Patient-Centered Medical Home, The Patient - Patient-Centered Outcomes Research, 2014, 7, 1, 115

    CrossRef

  5. 5
    Irene Park, Susan E. Sutherland, Lisa Ray, Courtenay Gilmore Wilson, Financial implications of pharmacist-led Medicare annual wellness visits, Journal of the American Pharmacists Association, 2014, 54, 4, 435

    CrossRef

  6. 6
    Marcello Tonelli, The Roads Less Traveled? Diverging Research and Clinical Priorities for Dialysis Patients and Those With Less Severe CKD, American Journal of Kidney Diseases, 2014, 63, 1, 124

    CrossRef